Clinical trial
Development Of A Non-Interventional Diagnostic Ngs-Based Assay Of Blood Samples Of Sepsis Patients For Rapid Bacterial Identification Based On Next Generation Sequencing.
NCT06141395 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development Of A Non-Interventional Diagnostic Ngs-Based Assay Of Blood Samples Of Sepsis Patients For Rapid Bacterial Identification Based On Next Generation Sequencing.
- Lead sponsor
- Hellenic Institute for the Study of Sepsis
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 16, 2023
- Completion date
- March 14, 2024
- Enrollment
- 100 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute pyelonephritis, bacteremia, biliary tract infection, pneumonia